Skip to main content

Table 1 Baseline characteristics of the study population (n = 146)

From: The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial

 

Interventionn = 71

Controln = 75

Sociodemographic characteristics

  

Mean age, years

60.4 (13.1)

59.6 (8.4)

Gender male, n (%)

60 (84.5)

53 (70.7)

 Education Lower education, n (%)

20 (28.6)

27 (37.0)

 Intermediate education, n (%)

32 (45.7)

27 (37.0)

 Higher education, n (%)

18 (25.7)

19 (26.0)

Marital or cohabitation status, n (%)

49 (69.0)

54 (72.0)

Working status: Paid job, n (%)

23 (32.4)

28 (37.3)

Ethnic minority, n (%)

8 (11.3)

12 (16.0)

Prognostic factors

  

Clinical characteristics of CVD

  

Cardiology patients, n (%)

60 (84.5)

63 (84.0)

 NYHA I a

34 (47.9)

30 (40.0)

 NYHA II a

24 (33.8)

30 (40.0)

 NYHA III a

2 (2.8)

3 (4.0)

Vascular patients, n (%)

11 (15.5)

12 (16.0)

 PAV I b

4 (5.6)

5 (6.7)

 PAV II b

6 (8.5)

6 (8.0)

 PAV III b

1 (1.4)

0 (0.0)

Angina Pectoris, n (%)

6 (8.5%)

5 (6.7)

Myocardial Infarction, n (%)

58 (81.7)

62 (82.7)

Coronary Artery Bypass Graft, n (%)

26 (36.6)

23 (30.7)

Percutaneous Coronary Intervention, n (%)

31 (43.7)

38 (50.7)

Cerebrovascular Accident, n (%)

9 (12.7)

4 (5.3)

Comorbidity Diabetes Mellitus, n (%)

18 (25.4)

14 (18.7)

At risk for depression (CES-D score ≥ 16), n (%)

19 (26.8)

20 (26.7)

Family history of CVD

31 (43.7)

34 (45.3)

  1. Numbers are mean (SD) unless stated otherwise.
  2. CVD = cardiovascular disease; aNYHA category among cardiology patients; bPAV category among vascular patients.